Apollo Endosurgery (APEN) Misses Q4 EPS by 47c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2018 Results
March 18, 2019 8:00 AM EDTConference Call to Discuss Results Today at 7:30 a.m. CT / 8:30 a.m. ET
AUSTIN, Texas--(BUSINESS WIRE)-- Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the fourth quarter and year ended December31, 2018.
Highlights
Fourth quarter ESS revenue contributed 64% of continuing product sales and increased 46% ESS revenue for the full year 2018 of $23.4 million increased 42% compared to 2017 Sale of the Surgical product line completed on... More